Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Patsner

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Gynecologic Oncology|March 1, 1986
cis-Diamminedichloroplatinum plus dimethyl-triazenoimidazole carboxamide as second- and third-line chemotherapy for sarcomas of the female pelvisM S Piver, S B Lele, B Patsner
European Journal of Gynaecological Oncology|January 1, 1989
Use of serum CA-125 levels to monitor therapy of patients with advanced or recurrent endometrial carcinomaB Patsner, D J Tenhoppen, W J Mann
American Journal of Obstetrics and Gynecology|February 1, 1990
Use of serum CA 125 measurement in posttreatment surveillance of early-stage endometrial carcinomaB Patsner, J W Orr, W J Mann
Gynecologic Oncology|May 1, 1988
Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinomaB Patsner, W J Mann, M Vissicchio, et al.
Gynecologic Oncology|May 1, 1989
Management of lymphocysts after radical gynecologic surgeryW J Mann, F Vogel, B Patsner, et al.
Journal of the National Cancer Institute|April 6, 1988
Preoperative serum CA-125 levels in patients with surgical stage I invasive ovarian adenocarcinomaW J Mann, B Patsner, H Cohen, et al.
Archives of Gynecology and Obstetrics|January 1, 1988
Herpetiform cutaneous metastases following negative second look laparatomy for ovarian adenocarcinomaB Patsner, W J Mann, J Chumas, et al.
American Journal of Obstetrics and Gynecology|February 1, 1988
Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinomaB Patsner, W J Mann, H Cohen, et al.
Gynecologic Oncology|July 1, 1990
Intestinal complications associated with use of the Dexon mesh sling in gynecologic oncology patientsB Patsner, W J Mann, E Chalas, et al.
Gynecologic Oncology|April 1, 1990
Morbidity and mortality of stapled anastomoses on a gynecologic oncology service: a retrospective reviewE Chalas, W J Mann, C P Westermann, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|March 1, 1986
cis-Diamminedichloroplatinum plus dimethyl-triazenoimidazole carboxamide as second- and third-line chemotherapy for sarcomas of the female pelvisM S Piver, S B Lele, B Patsner
European Journal of Gynaecological Oncology|January 1, 1989
Use of serum CA-125 levels to monitor therapy of patients with advanced or recurrent endometrial carcinomaB Patsner, D J Tenhoppen, W J Mann
American Journal of Obstetrics and Gynecology|February 1, 1990
Use of serum CA 125 measurement in posttreatment surveillance of early-stage endometrial carcinomaB Patsner, J W Orr, W J Mann
Gynecologic Oncology|May 1, 1988
Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinomaB Patsner, W J Mann, M Vissicchio, et al.
Gynecologic Oncology|May 1, 1989
Management of lymphocysts after radical gynecologic surgeryW J Mann, F Vogel, B Patsner, et al.
Journal of the National Cancer Institute|April 6, 1988
Preoperative serum CA-125 levels in patients with surgical stage I invasive ovarian adenocarcinomaW J Mann, B Patsner, H Cohen, et al.
Archives of Gynecology and Obstetrics|January 1, 1988
Herpetiform cutaneous metastases following negative second look laparatomy for ovarian adenocarcinomaB Patsner, W J Mann, J Chumas, et al.
American Journal of Obstetrics and Gynecology|February 1, 1988
Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinomaB Patsner, W J Mann, H Cohen, et al.
Gynecologic Oncology|July 1, 1990
Intestinal complications associated with use of the Dexon mesh sling in gynecologic oncology patientsB Patsner, W J Mann, E Chalas, et al.
Gynecologic Oncology|April 1, 1990
Morbidity and mortality of stapled anastomoses on a gynecologic oncology service: a retrospective reviewE Chalas, W J Mann, C P Westermann, et al.
Pageof 8